Biosig Technologies Pre-Tax Profit Margin 2012-2024 | BSGM
Biosig Technologies pre-tax profit margin from 2012 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Biosig Technologies Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2024-12-31 | $0.00B | $-0.01B | 0.00% |
| 2024-06-30 | $0.00B | $-0.02B | 0.00% |
| 2023-12-31 | $0.00B | $-0.03B | 0.00% |
| 2023-09-30 | $0.00B | $-0.03B | 0.00% |
| 2023-03-31 | $0.00B | $-0.03B | 0.00% |
| 2022-12-31 | $0.00B | $-0.03B | 0.00% |
| 2022-09-30 | $0.00B | $-0.03B | 0.00% |
| 2022-06-30 | $0.00B | $-0.03B | 0.00% |
| 2022-03-31 | $0.00B | $-0.03B | 0.00% |
| 2021-12-31 | $0.00B | $-0.03B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.033B | $0.000B |
| BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals. The Company's first product, PURE EP (tm) System, is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory. | |||